CMS

00867

----

Current ValuationThe current P/E ratio is 14.05, within the reasonable range, cheaper than 28.83% of the time in the past 5 years, and the industry ranks 16/52, the industry Median 6.64.

14.05xP/E

Stock priceHK$10.20Earnings per shareHK$0.73

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 6.64x

09182736

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 6.64x

0x20x40x60x80x100x

P/E ratio
Name/Symbol
01093HKCSPC PHARMA	11.96x	130.24%	HK$102.32B
02196HKFOSUN PHARMA	11.61x	20.48%	HK$45.31B
02096HKSIMCERE PHARMA	15.64x	34.13%	HK$28.30B
00867HKCMS	14.05x	41.06%	HK$24.82B
00512HKGRANDPHARMA	14.69x	45.32%	HK$16.29B
02005HKSSY GROUP	15.63x	24.61%	HK$7.93B
00460HKSIHUAN PHARM	18.50x	322.94%	HK$6.43B
03613HKTONGRENTANGCM	13.35x	15.96%	HK$4.81B
01666HKTONG REN TANG	11.26x	17.93%	HK$3.98B
00719HKSHANDONG XINHUA	15.45x	--	HK$3.83B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.